NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE180297 Query DataSets for GSE180297
Status Public on Oct 15, 2021
Title Dual checkpoint blockade of CD47 and PD-L1 using a novel affinity-tuned bispecific antibody maximizes anti-tumor immunity
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Expression profiling by array
Summary This SuperSeries is composed of the SubSeries listed below.
 
Overall design Refer to individual Series
 
Citation(s) 34599020
Submission date Jul 17, 2021
Last update date Apr 22, 2022
Contact name Wenjing Yanf
E-mail(s) wenjing.yang3@pfizer.com
Organization name Pfizer
Department Oncology
Street address 10770 Science Center Drive
City San Diego
State/province CA
ZIP/Postal code 92121
Country USA
 
Platforms (2)
GPL19057 Illumina NextSeq 500 (Mus musculus)
GPL30261 NanoString nCounter Mouse RNA Expression Assay
Samples (33)
GSM5373556 Mouse CD47 D20
GSM5373557 mouse CD47 D24
GSM5373558 mouse CD47 PDL1 Bispecific D20
This SuperSeries is composed of the following SubSeries:
GSE177053 Dual checkpoint blockade of CD47 and PD-L1 using a novel affinity-tuned bispecific antibody maximizes anti-tumor immunity (NanoString)
GSE180296 Dual checkpoint blockade of CD47 and PD-L1 using a novel affinity-tuned bispecific antibody maximizes anti-tumor immunity (scRNA-Seq)
Relations
BioProject PRJNA747707

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE180297_RAW.tar 220.5 Mb (http)(custom) TAR (of MTX, TSV, XLSX)
SRA Run SelectorHelp

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap